TP53 oncomorphic mutations predict resistance to platinum‑ and taxane‑based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Samuel R Mueting Kimberly K Leslie |
| Publication date | November 11, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |